Literature DB >> 2196095

The penicillins today.

R Finch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196095      PMCID: PMC1663030          DOI: 10.1136/bmj.300.6735.1289

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  27 in total

1.  Carbenicillin-associated hypokalemic alkalosis.

Authors:  S V Cabizuca; K B Desser
Journal:  JAMA       Date:  1976-08-23       Impact factor: 56.272

2.  Induction of the beta-lactamases of a strain of Pseudomonas aeruginosa, Morganella morganii and Enterobacter cloacae.

Authors:  T H Farmer; C Reading
Journal:  J Antimicrob Chemother       Date:  1987-03       Impact factor: 5.790

Review 3.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

4.  Increase in bronchopulmonary infection due to branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; S Capewell; M J Croughan; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

Review 5.  World-wide development of antibiotic resistance in pneumococci.

Authors:  P C Appelbaum
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

6.  A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.

Authors:  D Greenwood; A Eley
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

7.  Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.

Authors:  M I Thompson; M E Russo; B J Saxon; E Atkin-Thor; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

8.  Mezlocillin for treatment of infections in cancer patients.

Authors:  B F Issell; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections.

Authors:  M J Gribble; A W Chow; S C Naiman; J A Smith; W R Bowie; S L Sacks; L Grossman; N Buskard; G H Growe; L H Plenderleith
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

Review 10.  Infections caused by Pseudomonas aeruginosa.

Authors:  G P Bodey; R Bolivar; V Fainstein; L Jadeja
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr
View more
  1 in total

Review 1.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.